TS Financial Group (TSFG)’s Adaptive Biotechnologies ADPT Stock Holding History

TS Financial Group (TSFG)’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-100	Closed	–	–	753
2023 Q4	$0	Hold	100	–	–	﹤0.01%	869
2023 Q3	$1K	Hold	100	–	–	﹤0.01%	876
2023 Q2	$1K	Hold	100	–	–	﹤0.01%	874
2023 Q1	$1K	Hold	100	–	–	﹤0.01%	858
2022 Q4	$1K	Hold	100	–	–	﹤0.01%	875
2022 Q3	$1K	Hold	100	–	–	﹤0.01%	848
2022 Q2	$1K	Hold	100	–	–	﹤0.01%	861
2022 Q1	$1K	Hold	100	–	–	﹤0.01%	829
2021 Q4	$3K	Hold	100	–	–	﹤0.01%	701
2021 Q3	$3K	Hold	100	–	–	﹤0.01%	685
2021 Q2	$4K	Buy	+100	New	+$3.89K	﹤0.01%	664

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

AAP

Aristotle Atlantic Partners Sarasota, Florida $2.14B AUM 37.01% 1-Year Est. Return

TS Financial Group (TSFG)'s ADPT Position: Q1 2024 in Review

TS Financial Group (TSFG) sold out of Adaptive Biotechnologies (ADPT) in Q1 2024, closing a stake of 100 shares.

TS Financial Group (TSFG) first reported a position in ADPT in Q2 2021 and held it in 11 quarters. The position peaked at $4K in Q2 2021. 190 funds tracked by Wall St. Rank hold ADPT as of Q1 2024.

TS Financial Group (TSFG) reported no remaining Adaptive Biotechnologies position as of Q1 2024 after selling out during the quarter.
TS Financial Group (TSFG) sold 100 Adaptive Biotechnologies shares in Q1 2024.
TS Financial Group (TSFG) first reported a position in Adaptive Biotechnologies in Q2 2021 and held it in 11 quarters.
TS Financial Group (TSFG)'s Adaptive Biotechnologies position peaked at $4K in Q2 2021.
190 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2024.

Based on TS Financial Group (TSFG)'s 13F filing for Q1 2024, filed 16 Apr 2024.